arrow
E

Eirik Klami Kristianslund

Diakonhjemmet Hospital
H指数:26
被引数:3,214

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Health-Related Quality of Life in Disease-Modifying Antirheumatic Drug-Treated Adults With Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population

与类风湿关节炎和普通人群相比,接受疾病修饰抗风湿药物治疗的幼年特发性关节炎成年患者的健康相关生活质量

2026-01-010
PRE
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

欧洲各国在组织治疗银屑病关节炎和轴向脊柱关节炎患者方面的国家医疗体系存在差异。

2025-06-010
OAAI
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline
2024-10-282
PRE
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic

类风湿关节炎或银屑病关节炎患者的间质性肺病起始生物制剂和对照: 来自5个北欧的数据

2024-09-011
OA
Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study

中轴型脊柱关节炎患者报告愿意使用远程护理,并对电子患者报告的结果指标表现出很高的依从性: 一项为期18个月的观察性研究

2024-08-210
OAAI
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatment
2024-07-011
OAAI
THE IMPACT OF SMOKING STATUS ON ONE-YEAR SECUKINUMAB RETENTION RATE IN 1,684 PATIENTS WITH PSORIATIC ARTHRITIS: REAL-WORLD RESULTS FROM THE EUROSPA COLLABORATION

吸烟状况对1,684例银屑病关节炎患者一年SECUKINUMAB保留率的影响:EUROSPA合作的真实世界结果

2024-06-010
PRE
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
2024-04-151
OA
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies
2024-03-012
OAAI
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration

开发和外部验证类风湿关节炎患者甲氨蝶呤治疗结果的多项式预测模型: 来自国际合作的结果

2024-02-011
OA
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
2023-10-016
OA
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
2022-04-2932
OAAI
Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis

非肿瘤坏死因子抑制剂作为类风湿关节炎的第一种生物制剂失败后第二种生物制剂的有效性

2021-03-015
PRE